FOXO Technologies Inc. (NYSEAMERICAN:FOXO) Short Interest Down 28.9% in February

FOXO Technologies Inc. (NYSEAMERICAN:FOXO) was the recipient of a significant drop in short interest in February. As of February 15th, there was short interest totalling 895,600 shares, a drop of 28.9% from the January 31st total of 1,260,000 shares. Currently, 4.3% of the company’s stock are short sold. Based on an average trading volume of 9,270,000 shares, the days-to-cover ratio is presently 0.1 days.

FOXO Technologies Stock Performance

Shares of FOXO stock traded up $0.01 during mid-day trading on Wednesday, hitting $0.17. 833,765 shares of the stock were exchanged, compared to its average volume of 14,552,096. The firm’s fifty day moving average price is $0.28. FOXO Technologies has a 12-month low of $0.13 and a 12-month high of $1.30.

Institutional Trading of FOXO Technologies

An institutional investor recently bought a new position in FOXO Technologies stock. Jane Street Group LLC acquired a new position in shares of FOXO Technologies Inc. (NYSEAMERICAN:FOXO) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 117,047 shares of the company’s stock, valued at approximately $34,000. Jane Street Group LLC owned about 0.67% of FOXO Technologies at the end of the most recent reporting period. Institutional investors and hedge funds own 44.89% of the company’s stock.

About FOXO Technologies

FOXO Technologies Inc engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging.